Strengthening research capacity

P. falciparum genetic structure before and after the development of artemisinin based combination therapy in Malawi

Lead researcher: 

Malawi replaced sulphadoxine-pyrimethamine (SP) with Coartem as the first-line treatment for malaria in November 2007. This project seeks to evaluate the impact of this treatment policy change on the genetic structure of parasites at a single location before and after the switch. The working hypothesis is that in areas where malaria transmission levels are decreasing due to sustained malaria control interventions, both the prevalence and complexity of multiple-genotype infections (MIs) will dramatically decline.

Status: The project is currently on hold while the PI completes a post-doc in the USA. Field work will commence in 2013.

Learn more about mentoring through our Open Access Mentoring Module.

Access the grant system (for MCDC members only)

Follow us:

Contact us

MCDC | London School of Hygiene & Tropical Medicine
Keppel Street